Key technical levels are the 52-week low of $31.47 and the 52-week high of $52.71. The stock is currently trading closer to the high, with support at the $40 level, which was tested in early July, and resistance at the $52.71 high. A breakout above the 52-week high would signal a continuation of the uptrend and could attract momentum buyers, while a breakdown below the $40 support could indicate a deeper correction. The stock's beta of 0.43 is significantly lower than the market, indicating that it is less volatile than the S&P 500, which may appeal to risk-averse investors. This low beta suggests that the stock's price movements are less sensitive to market swings, providing some downside protection in turbulent times.

The balance sheet appears manageable, with a debt-to-equity ratio of 0.57, which is moderate for the industry. The current ratio of 0.98 indicates that current liabilities slightly exceed current assets, which could pose a liquidity risk, but the company generates strong operating cash flow, with $1.655 billion in Q1 2026. Free cash flow was $626 million in Q1 2026, down from $1.0 billion in Q1 2025, but still positive. The return on equity (ROE) is 17.01%, which is solid, and the return on assets (ROA) is 6.07%. The company's ability to generate free cash flow is crucial for funding its dividend and share buybacks, and while the recent decline is notable, the overall financial health appears stable.